Autoantibody Reduction Regimen Improves Lungs, Survival: Study

Autoantibody Reduction Regimen Improves Lungs, Survival: Study

314152

Autoantibody Reduction Regimen Improves Lungs, Survival: Study

An autoantibody reduction regimen that combines three treatments improved lung function and survival in adults with idiopathic pulmonary fibrosis (IPF) who are experiencing acute symptom worsening, a small study suggests. Early, positive clinical responses predicted better long-term outcomes, and high levels of autoantibodies against epithelial markers before treatment were significantly associated with improved survival. The epithelium comprises one or more layers of cells that line most internal and external surfaces of the body and its…

You must be logged in to read/download the full post.